Pharma Journalist -

AstraZeneca has agreed to divest the prescription medicine rights to Nexium (esomeprazole) in Europe, as well as the global rights (excluding the US and Japan) to Vimovo …
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved INVOKANA (canagliflozin) to reduce the risk of…
Read More...

Lonza announced the acquisition of a controlling stake in Octane Biotech, with the right to acquire full ownership. The increase in equity share will allow Lonza to further develop the…
Read More...

Bioasis Technologies announced it has entered into a licensing agreement with a subsidiary of Prothena Corporation plc) (“Prothena”), granting Prothena certain rights to use the xB3…
Read More...

Rigel Pharmaceuticals announced that it had entered into an exclusive license and supply agreement with Kissei Pharmaceutical Co., Ltd. ("Kissei") to develop and commercialize TAVALISSE…
Read More...

Eli Lilly and Company and Dicerna Pharmaceuticals announced a global licensing and research collaboration focused on the discovery, development and commercialization of potential new…
Read More...

Charles River Laboratories International announced that it has entered into an exclusive partnership with Distributed Bio, Inc., a leader in the computational design and optimization of…
Read More...

Alcami Corporation announced its collaboration with Medicines Development for Global Health (MDGH), a not-for-profit Australian biopharmaceutical company dedicated to the development of…
Read More...

Aerie Pharmaceuticals announced that it has built and commenced operation of its GMP (Good Manufacturing Practices)-validated manufacturing facility for production of ophthalmic…
Read More...

Thermo Fisher Scientific Inc. completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global…
Read More...